Literature DB >> 19404038

[Endomyocardial disease: a case report].

Kumral Cağli1, Belma Uygur, Fatih Ozlü, Zehra Gölbaşi.   

Abstract

Endomyocardial disease is a form of restrictive cardiomyopathy, of unknown etiology, which occurs most commonly in tropical and subtropical areas. It is characterized by the formation of endomyocardial fibrosis of the apical and subvalvular regions of one or both ventricles. A 29-year-old male patient was admitted with restrictive cardiomyopathy and decompensated heart failure. Telecardiography showed cardiomegaly and right pleural effusion. Transthoracic echocardiography revealed preserved left ventricular systolic functions, biatrial dilatation, apical obliteration of both ventricles, increased endocardial echoreflectivity, and pericardial effusion. The right ventricular outflow tract was dilated. There was no endocardial thickening in this region. Doppler examination showed grade 3 mitral and tricuspid regurgitation. Ventriculograms showed apical obliteration of both ventricles, marked decrease in the size of the right ventricular cavity, significant dilatation of the right ventricular outflow tract and both atria, and severe mitral and tricuspid regurgitation. Laboratory findings showed no hypereosinophilia. Hepatic congestion, splenomegaly, and ascites were noted on abdominal ultrasonography. Following cardiac catheterization, the patient was placed on the waiting list for cardiac transplantation.

Entities:  

Mesh:

Year:  2009        PMID: 19404038

Source DB:  PubMed          Journal:  Turk Kardiyol Dern Ars        ISSN: 1016-5169


  2 in total

Review 1.  Endomyocardial Fibrosis: an Update After 70 Years.

Authors:  Ana Olga Mocumbi; J Russell Stothard; Paulo Correia-de-Sá; Magdi Yacoub
Journal:  Curr Cardiol Rep       Date:  2019-11-22       Impact factor: 2.931

2.  The changing pattern of endomyocardial fibrosis in South-west Nigeria.

Authors:  Patience Olayinka Akinwusi; Abiona Oluwadamilola Odeyemi
Journal:  Clin Med Insights Cardiol       Date:  2012-11-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.